153 related articles for article (PubMed ID: 28753646)
1. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.
Van Dyke AL; Lang Kuhs KA; Shiels MS; Koshiol J; Trabert B; Loftfield E; Purdue MP; Wentzensen N; Pfeiffer RM; Katki HA; Hildesheim A; Kemp TJ; Pinto LA; Chaturvedi AK; Safaeian M
PLoS One; 2017; 12(7):e0182359. PubMed ID: 28753646
[TBL] [Abstract][Full Text] [Related]
2. Circulating inflammation markers and prospective risk for lung cancer.
Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and variations in systemic immune and inflammation markers.
Shiels MS; Katki HA; Freedman ND; Purdue MP; Wentzensen N; Trabert B; Kitahara CM; Furr M; Li Y; Kemp TJ; Goedert JJ; Chang CM; Engels EA; Caporaso NE; Pinto LA; Hildesheim A; Chaturvedi AK
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274579
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
Shiels MS; Shu XO; Chaturvedi AK; Gao YT; Xiang YB; Cai Q; Hu W; Shelton G; Ji BT; Pinto LA; Kemp TJ; Rothman N; Zheng W; Hildesheim A; Lan Q
Carcinogenesis; 2017 Oct; 38(10):1004-1010. PubMed ID: 28981818
[TBL] [Abstract][Full Text] [Related]
5. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
[TBL] [Abstract][Full Text] [Related]
6. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
[TBL] [Abstract][Full Text] [Related]
7. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and risk of developing type 2 diabetes in women.
Hu FB; Meigs JB; Li TY; Rifai N; Manson JE
Diabetes; 2004 Mar; 53(3):693-700. PubMed ID: 14988254
[TBL] [Abstract][Full Text] [Related]
10. Circulating Inflammatory Markers Are Inversely Associated with Heart Rate Variability Measures in Type 1 Diabetes.
Wegeberg AL; Okdahl T; Fløyel T; Brock C; Ejskjaer N; Riahi S; Pociot F; Størling J; Brock B
Mediators Inflamm; 2020; 2020():3590389. PubMed ID: 32908447
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
[TBL] [Abstract][Full Text] [Related]
12. Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease.
Eldridge RC; Wentzensen N; Pfeiffer RM; Brinton LA; Hartge P; Guillemette C; Kemp TJ; Pinto LA; Trabert B
Cancer Causes Control; 2020 Apr; 31(4):309-320. PubMed ID: 32100190
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehyde.
Seow WJ; Zhang L; Vermeulen R; Tang X; Hu W; Bassig BA; Ji Z; Shiels MS; Kemp TJ; Shen M; Qiu C; Reiss B; Beane Freeman LE; Blair A; Kim C; Guo W; Wen C; Li L; Pinto LA; Huang H; Smith MT; Hildesheim A; Rothman N; Lan Q
Carcinogenesis; 2015 Aug; 36(8):852-7. PubMed ID: 25908645
[TBL] [Abstract][Full Text] [Related]
14. Social relationships and inflammatory markers: an analysis of Taiwan and the U.S.
Glei DA; Goldman N; Ryff CD; Lin YH; Weinstein M
Soc Sci Med; 2012 Jun; 74(12):1891-9. PubMed ID: 22483707
[TBL] [Abstract][Full Text] [Related]
15. Circulating inflammation markers and prostate cancer.
Ugge H; Downer MK; Carlsson J; Bowden M; Davidsson S; Mucci LA; Fall K; Andersson SO; Andrén O
Prostate; 2019 Aug; 79(11):1338-1346. PubMed ID: 31212389
[TBL] [Abstract][Full Text] [Related]
16. Host factors associated with serologic inflammatory markers assessed using multiplex assays.
McKay HS; Bream JH; Margolick JB; Martínez-Maza O; Phair JP; Rinaldo CR; Abraham AG; Jacobson LP
Cytokine; 2016 Sep; 85():71-9. PubMed ID: 27295613
[TBL] [Abstract][Full Text] [Related]
17. Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.
Loftfield E; Shiels MS; Graubard BI; Katki HA; Chaturvedi AK; Trabert B; Pinto LA; Kemp TJ; Shebl FM; Mayne ST; Wentzensen N; Purdue MP; Hildesheim A; Sinha R; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1052-60. PubMed ID: 25999212
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.
Kitahara CM; Trabert B; Katki HA; Chaturvedi AK; Kemp TJ; Pinto LA; Moore SC; Purdue MP; Wentzensen N; Hildesheim A; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2840-9. PubMed ID: 25249326
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).
Cesari M; Penninx BW; Newman AB; Kritchevsky SB; Nicklas BJ; Sutton-Tyrrell K; Tracy RP; Rubin SM; Harris TB; Pahor M
Am J Cardiol; 2003 Sep; 92(5):522-8. PubMed ID: 12943870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
